Fundraising Fox
/Companies
Sign in

Suono Bio

Medford, US · Founded 2016 · Delaware corporation · 5 known investors

Find your way into Suono Bio

Each arrow is one introduction. Sign up to fill in the first one.

1,324 people can intro you to C.

Ask Magali Hickey to introduce you to C. Giovanni Traverso

You →Magali · together at Syntis Bio →C.

633 people can intro you to Carl

Ask Jamie Chen to introduce you to Carl Schoellhammer

You →Jamie · together at DeciBio →Carl

Sign up to find every way you can get introduced to Suono Bio

  • Your email: who you already know at Suono Bio, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Suono Bio team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in
Biotech

Founders & leadership

Suono Bio was founded in 2016 by Giovanni Traverso, Robert Langer, and Carl Schoellhammer.

GTGiovanni Traverso
Giovanni TraversoCo-FounderGiovanni Traverso is a Professor of Mechanical Engineering at MIT, a gastroenterologist at Brigham and Women's Hospital and Harvard Medical School, and Associate Member of the Broad Institute. He holds a BA from Cambridge and a PhD from Johns Hopkins University, completed medical training at Cambridge, Brigham and Women's, and Massachusetts General Hospital, and conducted post-doctoral research under Robert Langer at MIT; his research has focused on molecular diagnostics for cancer detection and novel drug delivery and sensing technologies.
RL
Robert LangerCo-founder
CSCarl Schoellhammer
Carl SchoellhammerFounding CEO2017–2020Carl Schoellhammer has worked as a strategy consultant across the life science and biopharma sectors, with focus on advanced therapies including oligonucleotides, cell therapies, and gene therapies. His expertise spans pipeline prioritization and optimization, manufacturing, bioprocessing, and enabling technologies.
AS
Amy SchulmanNamed on SEC filing

Investors · 5

Taiwania CapitalreportedTaipei · $3M – $85M

How we know: funding news · Not right? Tell us

Also in the syndicate · 3

Mizuho Securities Principal InvestmentleadPolarisThe Engine

Reported raises · per SEC filings

Form D private placements

$14M disclosed across 3 rounds · 2017–2023

▶$500KraisedAug 2023 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • CARL SCHOELLHAMMERExecutive Officer, Director
  • FREDERICK SHANEDirector
  • GIOVANNI TRAVERSODirector
  • VICTORIA WANGDirector
  • SCOTT KELLOGGExecutive Officer, Director
  • ROBERT LANGERDirector
Offering amount
$3M
Amount sold
$500K
First sale
Aug 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$12.2MraisedJul 2021 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Carl SchoellhammerExecutive Officer, Director
  • Robert LangerDirector
  • Scott KelloggExecutive Officer, Director
  • Giovanni TraversoDirector
  • Frederick ShaneDirector
Offering amount
$15.2M
Amount sold
$12.2M
First sale
Mar 2021
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.3MraisedJun 2017 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Amy SchulmanDirector
  • Giovanni TraversoDirector
  • Robert LangerDirector
  • Carl SchoellhammerExecutive Officer, Director
Offering amount
$2M
Amount sold
$1.3M
First sale
Jun 2017
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase I2019$263.4K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

Who founded Suono Bio?
Suono Bio was founded by Giovanni Traverso, Robert Langer, Carl Schoellhammer in 2016.
Who are Suono Bio's investors?
Suono Bio's investors include Axil Capital, Taiwania Capital.
How much funding has Suono Bio raised?
Suono Bio has disclosed $14M raised across 3 rounds.
Where is Suono Bio headquartered?
Suono Bio is headquartered in Medford, US.